TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 4847-4858

  Abrahamsen, Hilde ^a   Baillie, George ^b   Ngai, Jacob ^a   Vang, Torkel ^a   Nika, Konstantina ^c   Ruppelt, Anja ^a   Mustelin, Tomas ^c   Zaccolo, Manuela ^d   Houslay, Miles ^b   Taskén, Kjetil ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

^d VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CD28 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE IV; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID RAFT; MEMBRANE STRUCTURE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 6344233216     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.4847     Document Type: Article

References (68)

1. Rubin, C. S. 1994. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim. Biophys. Acta 1224:467.
2. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474.
3. Kaupp, U. B., and R. Seifert. 2002. Cyclic nucleotide-gated ion channels. Physiol. Rev. 82:769.
4. Kawasaki, H., G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D. E. Housman, and A. M. Graybiel. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275.
5. Michel, J. J., and J. D. Scott. 2002. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42:235.
6. Tasken, K., and E. M. Aandahl. 2004. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84:137.
7. Zaccolo, M., and T. Pozzan. 2002. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295:1711.
8. Ledbetter, J. A., M. Parsons, P. J. Martin, J. A. Hansen, P. S. Rabinovitch, and C. H. June. 1986. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J. Immunol. 137:3299.
9. Skalhegg, B. S., B. F. Landmark, S. O. Doskeland, V. Hansson, T. Lea, and T. Jahnsen. 1992. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′,5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267:15707.
10. Houslay, M. D., and D. R. Adams. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370:1.
11. Conti, M., W. Richter, C. Mehats, G. Livera, J. Y. Park, and C. Jin. 2003. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278:5493.
12. Manganiello, V. C., and E. Degerman. 1999. Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents. Thromb. Haemost. 82:407.
13. Erdogan, S., and M. D. Houslay. 1997. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J. 32:165.
14. Ekholm, D., J. C. Mulloy, G. Gao, E. Degerman, G. Franchini, and V. C. Manganiello. 1999. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes. Biochem. Pharmacol. 58:935.
15. s-coupled receptor agonists: potential role in β2-adrenoreceptor desensitization. J. Biol. Chem. 273:20575.
16. Giembycz, M. A. 2002. Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far. Monaldi Arch. Chest Dis. 57:48.
17. Burnouf, C., and M. P. Pruniaux. 2002. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr. Pharm. Des. 8:1255.
18. Spina, D. 2003. Theophylline and PDE4 inhibitors in asthma. Curr. Opin. Pulm. Med. 9:57.
19. Perry, S. J., G. S. Baillie, T. A. Kohout, I. McPhee, M. M. Magiera, K. L. Ang, W. E. Miller, A. J. McLean, M. Conti, M. D. Houslay, and R. J. Lefkowitz. 2002. Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins. Science 298:834.
20. Arp, J., M. G. Kirchhof, M. L. Baroja, S. H. Nazarian, T. A. Chau, C. A. Strathdee, E. H. Ball, and J. Madrenas. 2003. Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation. Mol. Cell. Biol. 23:8042.
21. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569.
22. Montixi, C., C. Langlet, A. M. Bernard, J. Thimonier, C. Dubois, M. A. Wurbel, J. P. Chauvin, M. Pierres, and H. T. He. 1998. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17:5334.
23. Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723.
24. Samelson, L. E. 2002. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20:371.
25. Okada, M., and H. Nakagawa. 1989. A protein tyrosine kinase involved in regulation of pp60c-src function. J. Biol. Chem. 264:20886.
26. tck at Tyr-505 and down regulates its catalytic activity. EMBO J. 11:2919.
27. Vang, T., K. M. Torgersen, V. Sundvold, M. Saxena, F. O. Levy, B. S. Skalhegg, V. Hansson, T. Mustelin, and K. Tasken. 2001. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193:497.
28. Vang, T., H. Abrahamsen, S. Myklebust, V. Horejsi, and K. Tasken. 2003. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J. Biol. Chem. 278:17597.
29. Aandahl, E. M., P. Aukrust, B. S. Skalhegg, F. Muller, S. S. Froland, V. Hansson, and K. Tasken. 1998. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12:855.
30. Torgersen, K. M., T. Vang, H. Abrahamsen, S. Yaqub, V. Horejsi, B. Schraven, B. Rolstad, T. Mustelin, and K. Tasken. 2001. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J. Biol. Chem. 276:29313.
31. Huston, E., L. Pooley, P. Julien, G. Scotland, I. McPhee, M. Sullivan, G. Bolger, and M. D. Houslay. 1996. The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J. Biol. Chem. 271:31334.
32. Huston, E., S. Lumb, A. Russell, C. Catterall, A. H. Ross, M. R. Steele, G. B. Bolger, M. J. Perry, R. J. Owens, and M. D. Houslay. 1997. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem. J. 328:549.
33. 2-terminal UCR regions. J. Biol. Chem. 275:16609.
34. Zhang, W. G., R. P. Trible, and L. E. Samelson. 1998. LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9:239.
35. Drevot, P., C. Langlet, X. J. Guo, A. M. Bernard, O. Colard, J. P. Chauvin, R. Lasserre, and H. T. He. 2002. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J. 21:1899.
36. Marchmont, R. J., and M. D. Houslay. 1980. A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem. J. 187:381.
37. Aandahl, E. M., W. J. Moretto, P. A. Haslett, T. Vang, T. Bryn, K. Tasken, and D. F. Nixon. 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169:802.
38. McPhee, I., S. J. Yarwood, G. Scotland, E. Huston, M. B. Beard, A. H. Ross, E. S. Houslay, and M. D. Houslay. 1999. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B: consequences for rolipram inhibition. J. Biol. Chem. 274:11796.
39. Bolger, G. B., S. Erdogan, R. E. Jones, K. Loughney, G. Scotland, R. Hoffmann, I. Wilkinson, C. Farrell, and M. D. Houslay. 1997. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem. J. 328:539.
40. s target lipid rafts by default. Mol. Biol. Cell 12:685.
41. Abrahamsen, H., T. Vang, and K. Tasken. 2003. Protein kinase A intersects SRC signaling in membrane microdomains. J. Biol. Chem. 278:17170.
42. Stanners, J., P. S. Kabouridis, K. L. McGuire, and C. D. Tsoukas. 1995. Interaction between G proteins and tyrosine kinases upon T cell receptor CD3-mediated signaling. J. Biol. Chem. 270:30635.
43. Fields, T. A., and P. J. Casey. 1997. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 321:561.
44. i2 mediates α2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with Gα C-terminal antibodies. Proc. Natl. Acad. Sci. USA 86:7809.
45. 2+ channels by β-adrenergic agonists. Proc. Natl. Acad. Sci. USA 93:295.
46. + T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol. 118:1945.
47. Dykstra, M., A. Cherukuri, H. W. Sohn, S. J. Tzeng, and S. K. Pierce. 2003. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21:457.
48. i. Proc. Natl. Acad. Sci. USA 100:940.
49. Luttrell, L. M., and R. J. Lefkowitz. 2002. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115:455.
50. McDonald, P. H., C. W. Chow, W. E. Miller, S. A. Laporte, M. E. Field, F. T. Lin, R. J. Davis, and R. J. Lefkowitz. 2000. β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574.
51. DeFea, K. A., J. Zalevsky, M. S. Thoma, O. Dery, R. D. Mullins, and N. W. Bunnett. 2000. β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148:1267.
52. DeFea, K. A., Z. D. Vaughn, E. M. O'Bryan, D. Nishijima, O. Dery, and N. W. Bunnett. 2000. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. USA 97:11086.
53. Appleman, L. J., and V. A. Boussiotis. 2003. T cell anergy and costimulation. Immunol. Rev. 192:161.
54. Giembycz, M. A. 2002. Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far. Monaldi Arch. Chest Dis. 57:48.
55. Saxena, M., S. Williams, J. Brockdorff, J. Gilman, and T. Mustelin. 1999. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 274:11693.
56. Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675.
57. Baniyash, M., P. Garcia-Morales, E. Luong, L. E. Samelson, and R. D. Klausner. 1988. The T cell antigen receptor ζ chain is tyrosme phosphorylaled upon activation. J. Biol. Chem. 263:18225.
58. Chan, A. C., B. A. Irving, J. D. Fraser, and A. Weiss. 1991. The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA 88:9166.
59. Yablonski, D., T. Kadlecek, and A. Weiss. 2001. Identification of a phospholipase C-γ1 (PLC-γ1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-γ1 and NFAT. Mol. Cell. Biol. 21:4208.
60. Kammer, G. M., C. A. Boehm, S. A. Rudolph, and L. A. Schultz. 1988. Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway. Proc. Natl. Acad. Sci. USA 85:792.
61. Rockman, H. A., W. J. Koch, and R. J. Lefkowitz. 2002. Seven-transmembrane-spanning receptors and heart function. Nature 415:206.
62. MacKenzie, S. J., G. S. Baillie, I. McPhee, C. MacKenzie, R. Seamons, T. McSorley, J. Millen, M. B. Beard, G. van Heeke, and M. D. Houslay. 2002. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in upstream conserved region 1 (UCR1). Br. J. Pharmacol. 136:421.
63. Sette, C., and M. Conti. 1996. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase: involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271:16526.
64. Whitehurst, C. E., T. G. Boulton, M. H. Cobb, and T. D. Geppert. 1992. Extracellular signal-regulated kinases in T cells: anti-CD3 and 4 β-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. J. Immunol. 148:3230.
65. Li, L., C. Yee, and J. A. Beavo. 1999. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283:848.
66. Yang, G., K. W. McIntyre, R. M. Townsend, H. H. Shen, W. J. Pitts, J. H. Dodd, S. G. Nadler, M. McKinnon, and A. J. Watson. 2003. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 171:6414.
67. Acuto, O., S. Mise-Omata, G. Mangino, and F. Michel. 2003. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol. Rev. 192:21.
68. Michel, F., G. Attal-Bonnefoy, G. Mangino, S. Mise-Omata, and O. Acuto. 2001. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15:935.